Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rottenberg

Showing results (671-680 of 684) with videos related to

Pageof 69
Sort By:
Biorxiv : the Preprint Server for Biology|January 23, 2026
Viral transcriptional regulators extensively rewire host pathways through diverse mechanismsJaice T Rottenberg, Xing Liu, Anna Berenson, et al.
NPJ Precision Oncology|July 11, 2026
Aurora kinase A is a synthetic lethal target in FANCA-deficient cancersDilara Akhoundova, Martín González-Fernández, Aavash Baral, et al.
Science (New York, N.Y.)|February 19, 2026
The oncogenome of the domestic catBailey A Francis, Latasha Ludwig, Chang He, et al.
Nature|March 25, 2015
REV7 counteracts DNA double-strand break resection and affects PARP inhibitionGuotai Xu, J Ross Chapman, Inger Brandsma, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Cell|December 12, 2017
A Living Biobank of Breast Cancer Organoids Captures Disease HeterogeneityNorman Sachs, Joep de Ligt, Oded Kopper, et al.
Nature|July 20, 2018
The shieldin complex mediates 53BP1-dependent DNA repairSylvie M Noordermeer, Salomé Adam, Dheva Setiaputra, et al.
The Lancet. Oncology|January 8, 2019
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare ConsortiumEva Clemens, Marry M van den Heuvel-Eibrink, Renée L Mulder, et al.
Elife|August 23, 2017
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancerLaura Cato, Antje Neeb, Adam Sharp, et al.
Pageof 69

Showing results (671-680 of 684) with videos related to

Sort By:
Pageof 69
Biorxiv : the Preprint Server for Biology|January 23, 2026
Viral transcriptional regulators extensively rewire host pathways through diverse mechanismsJaice T Rottenberg, Xing Liu, Anna Berenson, et al.
NPJ Precision Oncology|July 11, 2026
Aurora kinase A is a synthetic lethal target in FANCA-deficient cancersDilara Akhoundova, Martín González-Fernández, Aavash Baral, et al.
Science (New York, N.Y.)|February 19, 2026
The oncogenome of the domestic catBailey A Francis, Latasha Ludwig, Chang He, et al.
Nature|March 25, 2015
REV7 counteracts DNA double-strand break resection and affects PARP inhibitionGuotai Xu, J Ross Chapman, Inger Brandsma, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Cell|December 12, 2017
A Living Biobank of Breast Cancer Organoids Captures Disease HeterogeneityNorman Sachs, Joep de Ligt, Oded Kopper, et al.
Nature|July 20, 2018
The shieldin complex mediates 53BP1-dependent DNA repairSylvie M Noordermeer, Salomé Adam, Dheva Setiaputra, et al.
The Lancet. Oncology|January 8, 2019
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare ConsortiumEva Clemens, Marry M van den Heuvel-Eibrink, Renée L Mulder, et al.
Elife|August 23, 2017
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancerLaura Cato, Antje Neeb, Adam Sharp, et al.
Pageof 69